Psychiatry AtlasMedication guide · United States

Antiseizure medicine; mood stabilizer for bipolar I maintenance

Lamotrigine (Lamictal, Lamictal XR, Lamlique)

Generic name
Lamotrigine
Brand names
Lamictal; Lamictal XR; Lamlique
Medication class
Antiseizure medicine; mood stabilizer for bipolar I maintenance
Forms covered
Immediate-release tablet; Tablet for oral suspension; Orally disintegrating tablet; Extended-release tablet; Oral suspension

Article updated: 2026-10-24 · Sources last checked: 2026-11-05

Medication Safety Alerts

Look-alike / sound-alike name

Show more (3)

High Alert

  • Community/ambulatory care: errors in the starting dose, dose increases or restarting can increase the risk of a life-threatening rash.

FDA Boxed Warning

Lamictal immediate-release tablets, orally disintegrating tablets and tablets for oral suspension; Lamictal XR extended-release tablets. Lamlique oral suspension.

Lamotrigine can cause life-threatening rashes, including Stevens–Johnson syndrome and toxic epidermal necrolysis. Risk is higher in children and with valproate, excessive starting doses, rapid dose increases or HLA-B*1502. A new rash needs immediate assessment; labeling directs stopping at the first sign unless clearly unrelated. Do not restart without medical advice.

Lamotrigine treats certain seizures and helps delay new mood episodes in adults with bipolar I disorder. Bipolar maintenance approvals include immediate-release Lamictal forms and Lamlique oral suspension; Lamictal XR is an epilepsy product.

Lamlique (oral suspension).

What to expect: The dose is introduced gradually for safety, so benefit may develop over several weeks.

Warning signs · Medicine forms
Sources last checked:
2026-11-05

What is this medicine used for?

FDA-approved uses

  • Bipolar I maintenance — Adults aged 18 and older. Delaying mood episodes after an acute episode has been treated with standard therapy. This is maintenance treatment, not established acute-episode treatment.Immediate-release tablet; Tablet for oral suspension; Orally disintegrating tablet; Oral suspension.
  • Epilepsy: treatment added to other medicines — Adults and children aged 2 and older. For focal (partial-onset) seizures, primary generalized tonic-clonic seizures, and generalized seizures associated with Lennox–Gastaut syndrome.Immediate-release tablet; Tablet for oral suspension; Orally disintegrating tablet; Oral suspension.
  • Epilepsy: conversion to a single medicine — People aged 16 and older. For focal seizures when changing from carbamazepine, phenytoin, phenobarbital, primidone or valproate as the single antiseizure medicine. This is a clinician-managed conversion, not a general approval to start it alone.Immediate-release tablet; Tablet for oral suspension; Orally disintegrating tablet; Oral suspension.
  • Lamictal XR: epilepsy treatment added to other medicines — People aged 13 and older. For focal seizures with or without secondary generalization and primary generalized tonic-clonic seizures. This extended-release indication does not include bipolar disorder.Extended-release tablet.
  • Lamictal XR: conversion to a single medicine — People aged 13 and older. For focal seizures when converting from one antiseizure medicine under a prescriber’s plan.Extended-release tablet.

Read more: Bipolar I Disorder.

What should I expect?

The dose is introduced gradually for safety, so benefit may develop over several weeks. In bipolar maintenance, the aim is a longer period without a new mood episode; this is different from treating an episode of mania or depression already under way.

Agree on a follow-up plan when treatment starts. Contact the prescriber if symptoms worsen, side effects disrupt daily life, or there is no useful improvement by the planned review; do not change the dose yourself.

How do I take it safely?

Take the exact prescribed product, with or without food. Follow the gradual starting schedule; faster increases raise serious-rash risk. Check the medicine name and form at each refill. Do not substitute Lamictal XR for an immediate-release form yourself.

Swallow standard and extended-release tablets whole; do not crush or chew them. Tablets for oral suspension may be chewed, swallowed, or dispersed as directed; orally disintegrating tablets dissolve in the mouth. Ask a pharmacist to demonstrate the instructions for your specific product.

Do not use if you have a known hypersensitivity to lamotrigine or an ingredient in the product. A previous serious reaction needs a prescriber’s assessment; do not try the medicine again yourself.

Discuss heart disease, heart-rhythm problems, unexplained fainting, kidney or liver problems, and any previous medicine-related rash before treatment. Some other medicines that affect the heart’s electrical signals can add risk.

Valproate, including valproic acid and divalproex, slows removal of lamotrigine and can increase exposure and rash risk. Carbamazepine, phenytoin, phenobarbital and primidone can speed its removal. Rifampin and some HIV medicines can also affect exposure. Tell the prescriber before starting or stopping any of these.

Estrogen-containing contraceptives can lower lamotrigine levels. Stopping them, changing them, or having a pill-free interval can raise levels. Other estrogen-containing treatments may also matter. Plan changes with the prescriber and pharmacist rather than adjusting lamotrigine yourself.

Ask about the reliability of your specific contraceptive and report unexpected bleeding or spotting. The evidence does not justify saying that every hormonal contraceptive will fail. Alcohol or other medicines that cause sleepiness may make practical tasks less safe; discuss your combination.

If you are pregnant or planning pregnancy, discuss treatment early. The current label describes pregnancy-registry findings that have not shown an overall increase in major birth defects, but observational data cannot guarantee absence of risk. Much of the evidence comes from epilepsy treatment. The risks of untreated illness also matter.

Lamotrigine levels may change during pregnancy and after delivery, so the treatment and monitoring plan may need review. Do not stop abruptly because of pregnancy without discussing the risks and a plan with your clinician.

Lamotrigine passes into breast milk. Discuss benefits, possible infant effects and alternatives with the care team. A baby who develops a rash, unusual sleepiness, poor feeding or poor weight gain needs prompt assessment; breathing difficulty needs emergency help. Breastfeeding decisions are individual, rather than a blanket safe-or-unsafe rule.

Age limits depend on the indication and product, as shown above. Approval for childhood epilepsy does not establish approval for childhood bipolar disorder. In older adults, other medicines and kidney or liver function deserve particular attention; fewer trial participants were aged 65 or older.

For a single missed dose, the U.S. Medication Guide says to take it when remembered unless it is almost time for the next dose. In that case, skip the missed dose. Do not take two doses together to make up for it. Ask a pharmacist if you are unsure what “almost time” means for your prescription.

If you have stopped taking lamotrigine or had an interruption, contact the prescriber before restarting. You may need to begin again gradually; do not resume your old dose based on a guessed number of days. Restarting after a rash requires particular caution.

Do not stop suddenly or change the amount on your own. Abrupt withdrawal can cause problems, including seizures. A clinician normally plans withdrawal, while an urgent adverse reaction may require a different approach. If you take too much, obtain immediate medical or poison-service advice; do not wait for symptoms.

Do not drive or do hazardous work until you know how it affects your balance, vision, and alertness.

Lamlique is a separately approved liquid in two concentrations: 5 mg/mL and 25 mg/mL. Check the concentration and prescribed volume with the pharmacist. Shake before each dose, measure with an oral dosing syringe, and discard the remainder 60 days after opening. Do not switch products yourself.

What side effects should I know about?

  • Headache, nausea or vomiting, dizziness, sleepiness, tiredness or difficulty sleeping can occur. Contact the prescriber if effects persist or interfere with daily life.
  • Blurred or double vision and unsteadiness can affect safe movement and driving. A rash belongs in the urgent-warning category, even if it initially seems mild.

Tell your prescriber about effects that are persistent, troublesome, or interfere with daily life.

Which warning signs need help?

  • Lamotrigine can cause a life-threatening skin reaction. Contact your healthcare professional immediately for a new rash, hives, blisters, peeling skin, or sores around the mouth or eyes. You need prompt assessment to decide whether treatment can continue. Seek emergency help for trouble breathing, swelling of the face or throat, or severe illness. Do not wait for a routine appointment.
  • Get urgent medical assessment for fever with swollen glands, unusual bruising or bleeding, yellow skin or eyes, or severe weakness. Serious immune reactions, including DRESS and the rare overactive immune response HLH, can affect several organs and may occur without a rash.
  • A severe headache with fever, stiff neck, vomiting or light sensitivity needs urgent assessment. Inflammation around the brain and spinal cord, called aseptic meningitis, is a reported serious reaction.
  • Seek urgent help for new abnormal heartbeats, fainting, chest symptoms or breathing difficulty, especially with known heart disease. Severe symptoms need emergency care.
  • Seek prompt help for new or worsening depression, unusual agitation or thoughts of self-harm. If you might act on those thoughts or cannot stay safe, seek emergency help now.

What else should I know to stay safe?

  • Follow the prescribed gradual increases. Starting too high or increasing too quickly raises serious-rash risk. After an interruption, contact the prescriber before restarting; the previous dose may be unsafe. Never restart after a rash without a specific medical assessment.
  • Do not use after an allergic reaction to lamotrigine or its ingredients. Review previous medicine-related rashes, heart disease or unexplained fainting, and kidney or liver problems. Certain medicines affecting the heart’s electrical signals can add risk.
  • Valproate can raise lamotrigine levels and rash risk; several seizure medicines, rifampin, and some HIV medicines also change levels. Starting or stopping estrogen-containing contraception or other estrogen treatment can change exposure. Have all changes checked and report unexpected bleeding or spotting.
  • Pregnancy and the period after delivery can change lamotrigine levels and the monitoring plan. Discuss pregnancy and breastfeeding early; breastfed infants need attention to feeding, alertness, weight, and rash. Do not stop abruptly on your own because seizures can occur. Alcohol and sedating medicines can worsen impairment.

Urgent help and crisis support · Emergency & Crisis Resources (US)

What can help day to day?

  • Slow dose increases are part of protecting you from serious rash, not simply a delay before treatment can begin. A treatment interruption can mean that the gradual start needs to be repeated.
  • Contraception changes can change lamotrigine levels. Include starting or stopping estrogen-containing contraception in your medication discussions, even if the lamotrigine prescription itself stays the same.

How does it work?

Lamotrigine affects the channels that help nerve cells produce electrical signals. Laboratory studies suggest that it can limit repeated firing, meaning the sending of electrical signals, and influence the release of chemical messengers. These findings help explain some of its actions, although scientists have not established exactly how they produce its benefits in bipolar disorder.

Explore more in Brain & Science: Lamotrigine and Electrical Signals.

How was this medicine developed?

Lamictal first received FDA approval for epilepsy in 1994. Its immediate-release forms later gained a bipolar I maintenance role. Lamictal XR was separately approved in 2009 and retains epilepsy-specific indications.

How do I say the name?

Lamotrigine: luh-MOH-trih-jeen. Capital letters show the stressed syllable.

Medicine forms and official information

Match the full name, release type and route on your prescription. Different formulations need their own prescribing instructions; do not switch or substitute them yourself.

Sources and References

Sources support the U.S. products described here. Product instructions can differ; use the information supplied with your own medicine.

  1. Lamictal prescribing information and Medication Guide (revised October 2025)
  2. Lamictal XR prescribing information and Medication Guide (revised October 2025)
  3. Lamotrigine: patient information
  4. Lamictal approval history and current product record
  5. Lamictal XR approval history
  6. Lamictal in-use labeling and patient guide
  7. Lamotrigine: Package Insert / Prescribing Information / MOA
  8. Lamlique oral suspension prescribing information and Medication Guide (revised September 2026)
  9. Lamotrigine: FDA approval letter
  10. Lamlique: Uses, Dosage, Side Effects, Warnings - Drugs.com
  11. Historical Lamictal labeling: bipolar maintenance approval
  12. Lamotrigine: benefits, common effects and pregnancy questions
  13. Lamotrigine and heart rhythm risk in people with heart disease
  14. Understanding prescribing outside an approved use
  15. Mental Health Medications
  16. What Is a Neurotransmitter?
  17. Interaction of the antiepileptic drug lamotrigine with recombinant rat brain type IIA Na+ channels and with native Na+ channels in rat hippocampal neurones — mechanism explanation

    Scope: Mechanism explanation only. Source sections checked: Abstract: voltage-, use- and state-dependent inhibition in cell experiments..

  18. Sodium-channel states in rat nerve-cell experiments by Kuo and Lu
  19. Lamotrigine chemical record: PubChem CID 3878
  20. Verified two-dimensional atoms and bonds for lamotrigine
  21. ISMP List of Confused Drug Names
  22. ISMP List of High-Alert Medications in Community/Ambulatory Care Settings

Giving medicine safely to children: family guide (PDF, 3 pages)

How information is checked

Was this article helpful?

Was this article helpful?

Sends your choice, article identifier, edition and optional issue to Psychiatry Atlas. No name, email or medical details are requested. Daily network codes help prevent spam; hosting may process technical information. This is not a promise of anonymity. Privacy details.

Enable JavaScript to send feedback.

Suggest a missing topic or describe a correction. Please keep personal medical information out of website feedback.

Back to top